scholarly article | Q13442814 |
P356 | DOI | 10.1093/JAC/DKT010 |
P8608 | Fatcat ID | release_pol7pklb25b43jfzogjhpv2tzu |
P932 | PMC publication ID | 3654221 |
P698 | PubMed publication ID | 23447139 |
P5875 | ResearchGate publication ID | 235750569 |
P50 | author | Ravirajsinh N Jadeja | Q43051817 |
Bilal El-Zahab | Q54364649 | ||
P2093 | author name string | Min Li | |
Isiah M Warner | |||
Daniel Hayes | |||
Jeffery A Hobden | |||
Marsha R Cole | |||
Marlene E Janes | |||
P2860 | cites work | Antiseptics and disinfectants: activity, action, and resistance | Q24550729 |
Nephrotoxic and hepatotoxic effects of triclosan and chlorhexidine in rats | Q28319763 | ||
Near-infrared fluorescent nanoGUMBOS for biomedical imaging | Q33638220 | ||
Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots | Q33989285 | ||
Chemical sensing in mammalian host-bacterial commensal associations | Q34006799 | ||
The mechanism of action of chlorhexidine | Q34239704 | ||
Drug synergism: its detection and applications | Q34337018 | ||
Options for the control of enterohaemorrhagic Escherichia coli in ruminants | Q35025039 | ||
Cationic antiseptics: diversity of action under a common epithet | Q36257280 | ||
Antimicrobial resistance of Escherichia coli and therapeutic implications | Q36292004 | ||
Association of 1-1 salts in water | Q36463403 | ||
Interaction index and different methods for determining drug interaction in combination therapy | Q36811252 | ||
Diet, Escherichia coli O157:H7, and cattle: a review after 10 years. | Q37436825 | ||
Verocytotoxin-producing Escherichia coli (VTEC). | Q37467549 | ||
Impact of the direct application of therapeutic agents to the terminal recta of experimentally colonized calves on Escherichia coli O157:H7 shedding. | Q41939923 | ||
Location of chlorhexidine in DMPC model membranes: a neutron diffraction study | Q43111995 | ||
In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid | Q43166557 | ||
Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material | Q44041868 | ||
Inflammatory response to different endodontic irrigating solutions. | Q44227251 | ||
Effects of the antibiotic ionophores monensin, lasalocid, laidlomycin propionate and bambermycin on Salmonella and E. coli O157:H7 in vitro | Q44282625 | ||
Effect of feeding the ionophores monensin and laidlomycin propionate and the antimicrobial bambermycin to sheep experimentally infected with E. coli O157:H7 and Salmonella typhimurium | Q44366106 | ||
Interaction of the bisbiguanides chlorhexidine and alexidine with phospholipid vesicles: evidence for separate modes of action | Q45152220 | ||
Basic microbiological techniques used in antibacterial drug discovery. | Q51296128 | ||
Design and analysis of drug combination experiments. | Q51968000 | ||
Some toxicological observations on chlorhexidine. | Q53852769 | ||
Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium- and pyridinium-type ionic liquids. | Q54364540 | ||
Antimicrobial susceptibility of Escherichia coli O157 and other enterohaemorrhagic Escherichia coli isolated in Italy. | Q54590976 | ||
The membrane destabilising action of the antibacterial agent chlorhexidine | Q72080168 | ||
The use of chlorhexidine | Q78415214 | ||
Structure and magnetic behavior of transition metal based ionic liquids | Q80478728 | ||
Systemic toxicity following ingestion of the chlorhexidine gluconate solution: a case report | Q83173047 | ||
Enhanced membrane transport of pharmaceutically active protic ionic liquids | Q84972776 | ||
Solubility properties of chlorhexidine salts | Q94706597 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
P304 | page(s) | 1312-1318 | |
P577 | publication date | 2013-02-26 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | Minimizing human infection from Escherichia coli O157:H7 using GUMBOS | |
P478 | volume | 68 |
Search more.